Implantica announces excellent RefluxStop™ investigator initiated study results published in Scientific Reports, a Nature journal
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces the independent study “Multicentric short term and safety study of ineffective esophageal motility (IEM) patients treated with RefluxStop device” was recently published in Nature Scientific Reports.This investigator-initiated independent multicenter study was conducted at the General Hospital of the Medical University of Vienna, Austria, and King Edward VII Hospital in London, UK, from 2021 through 2023. All 40 patients had Ineffective Esophageal Motility (IEM)